Modified thoracostomy window as a surgical treatment for chronic pleuropulmonary infections

Area of Science:

• Thoracic Surgery
• Infectious Diseases
• Surgical Techniques

Background:

• Empyema often necessitates surgical intervention, with procedures like the Clagett pleural window and Eloesser flap used as last resorts.
• Up to 30% of empyema patients require surgical management.
• Conventional thoracic windows are established but may have associated morbidities.

Purpose of the Study:

• To compare the postoperative outcomes of patients undergoing a conventional thoracic window versus a modified technique.
• To evaluate the efficacy and safety of a novel modified thoracic window approach for managing thoracic infections.

Main Methods:

• A retrospective cohort study was conducted from 2012 to 2023.
• Patients underwent either a conventional thoracic window or a modified technique involving costal arch resection and Alexis retractor use.
• Postoperative outcomes, including operative time, blood loss, hospital stay, and wound closure, were analyzed.

Main Results:

• The modified technique group (45% of procedures) demonstrated significantly shorter operative times (62 vs. 121 minutes) and less blood loss (78 vs. 245 mL) compared to the conventional group (55%).
• Hospital stay was markedly reduced in the modified group (9 vs. 40 days), with spontaneous closure observed in 10 patients versus none in the conventional group.
• While time to window closure showed no significant difference, the conventional group had a wider interval (IQR, 223-1,007 days) than the modified group (IQR, 154-417 days).

Conclusions:

• The modified thoracic window technique offers significant benefits, including reduced operative time, blood loss, and length of hospital stay.
• The modified technique facilitates spontaneous wound closure, potentially reducing the need for further surgical intervention.
• Further research with larger patient cohorts is warranted to fully ascertain the impact of this modified approach.